Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000155

Chairperson & CEO sold 9,500 shares at an average $576.47 ($5,476,462)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

20 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-01 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-01 Sale : show line 2 in the form 10b5-1 −120 $560.05 $67,206 333,823 I
2026-10-01 Sale : show line 3 in the form 10b5-1 −80 $561.68 $44,934 333,743 I
2026-10-01 Sale : show line 4 in the form 10b5-1 −160 $563.31 $90,130 333,583 I
2026-10-01 Sale : show line 5 in the form 10b5-1 −94 $567.90 $53,383 333,489 I
2026-10-01 Sale : show line 6 in the form 10b5-1 −306 $569.65 $174,314 333,183 I
2026-10-01 Sale : show line 7 in the form 10b5-1 −534 $570.55 $304,673 332,649 I
2026-10-01 Sale : show line 8 in the form 10b5-1 −320 $571.52 $182,888 332,329 I
Open-market sales · 9,500 sh · avg $576.47 · $5,476,462

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-01 Exercise or conversion : show line 21 in the form 10b5-1 Stock Option −9,500 318,910 I
Loading xslF345X06/primarydocument.xml…